ER-positive breast cancer
1 paper
- Humans1
Trial sponsors
Company3 trialsPhase 31,700 people
Company1 trialPhase 1134 people
1 trialPhase 3300 people
European Organisation for Research and Treatment of Cancer - EORTC
1 trialPhase 3220 people
2 trialsPhase 223 people
Dartmouth-Hitchcock Medical Center
1 trialPhase 2178 people
1 trialPhase 285 people
National Taiwan University Hospital
1 trialPhase 242 people
Latest
3 in 12 monthsBritish Journal of Cancer
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis
Cohort study of 1,223 peopleBiomarkers
International Journal of Epidemiology
Mechanisms underlying the effect of adiposity on risk of post-menopausal oestrogen receptor-positive breast cancer: an interventional mediation analysis
Cohort study of 1,260 peopleReproductive system
Nature Aging
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women
Case-control study in peopleInflammation